Diazepam and Erysipelas - a phase IV clinical study of FDA data

Summary:

Erysipelas is reported as a side effect among people who take Diazepam (diazepam), especially for people who are female, 60+ old, also take Prednisolone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Erysipelas when taking Diazepam. It is created by eHealthMe based on reports of 105,904 people who have side effects when taking Diazepam from the FDA, and is updated regularly.

What is Diazepam?

Diazepam has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 108,384 Diazepam users. Check the latest studies of Diazepam.

What is Erysipelas?

Erysipelas (bacterial skin infection) is found to be associated with 451 drugs and 645 conditions by eHealthMe. Check the latest studies of Erysipelas.

On Jul, 26, 2026

105,904 people reported to have side effects when taking Diazepam.
Among them, 15 people (0.01%) have Erysipelas.

Among these 15 people:

What is the gender of people who have Erysipelas when taking Diazepam? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Erysipelas when taking Diazepam? *

What are other drugs people take besides Diazepam? *

What are other side effects people have besides Erysipelas? *

Cardiac Failure: 5 people, 33.33%
General Physical Health Deterioration (weak health status): 4 people, 26.67%
Wound Infection: 3 people, 20.00%
Cryptogenic Cirrhosis (diseases of the live by cryptococcal): 3 people, 20.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 20.00%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 20.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 20.00%
Weakness: 3 people, 20.00%
Pvt: 3 people, 20.00%
Dizziness: 2 people, 13.33%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 33.33%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 6.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.67%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 1 person, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%
Infection: 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Dizziness: 1 person, 6.67%
Disease Complication: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Diazepam and have Erysipelas?

- Check whether Erysipelas is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diazepam:

Diazepam (108,384 reports)

Erysipelas treatments and more:

Erysipelas (8,077 reports)

Browse all side effects of Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erysipelas:

Erysipelas (451 drugs)

Browse all the conditions that are associated with Erysipelas:

Erysipelas (645 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diazepam (the active ingredients of Diazepam) and Diazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.